Eckhouse, S. R., Purcell, B. P., McGarvey, J. R., Lobb, D., Logdon, C. B., Doviak, H., … Spinale, F. G. (2014). Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction. Science Translational Medicine, 6(223). https://doi.org/10.1126/scitranslmed.3007244

Eckhouse, Shaina R., Brendan P. Purcell, Jeremy R. McGarvey, David Lobb, Christina B. Logdon, Heather Doviak, Jason W. O’Neill, et al. “Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction.” Science Translational Medicine 6, no. 223 (February 12, 2014). https://doi.org/10.1126/scitranslmed.3007244.

Eckhouse SR, Purcell BP, McGarvey JR, Lobb D, Logdon CB, Doviak H, et al. Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction. Science Translational Medicine. 2014 Feb 12;6(223).

Eckhouse, Shaina R., et al. “Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction.” Science Translational Medicine, vol. 6, no. 223, American Association for the Advancement of Science (AAAS), Feb. 2014. Crossref, doi:10.1126/scitranslmed.3007244.

Eckhouse SR, Purcell BP, McGarvey JR, Lobb D, Logdon CB, Doviak H, O’Neill JW, Shuman JA, Novack CP, Zellars KN, Pettaway S, Black RA, Khakoo A, Lee T, Mukherjee R, Gorman JH, Gorman RC, Burdick JA, Spinale FG. Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction. Science Translational Medicine. American Association for the Advancement of Science (AAAS); 2014 Feb 12;6(223).